We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Empresaria Group Plc | LSE:EMR | London | Ordinary Share | GB00B0358N07 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 31.00 | - | 0.00 | 07:30:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Employment Agencies | 250.3M | -2.9M | -0.0591 | -4.48 | 13M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/5/2018 15:26 | Just to mention that EMR will have a stand and be presenting at our MelloSouth event in Hever,Kent on 14th June and all shareholders and potential investors are welcome to attend EMR have presented at our Mello Central event before and we are very pleased to welcome them so this is an ideal opportunity to meet the management and hear about their strategy following the profit warning that seems to have halved the share price and whether a recovery could be in progress under the new CEO. Do come and join us at this quality event and there will be at least 25 other companies to meet plus some fabulous keynote speakers and a large number of fund managers presenting and on panel sessions. | davidosh | |
25/5/2018 11:20 | Allenby; Whilst we are sorry to see Joost leave the Board we are pleased that he can utilise his considerable experience as a consultant to the Group with particular responsibilities for the important German and Austrian markets. We see the appointment of Spencer as an obvious successor to Joost. He has built up an intimate knowledge of the Group's subsidiaries over many years and we suspect that together with his management team will continue to implement Empresaria's buy and build strategy to good effect. We believe that the Group remains in very capable hands. | davebowler | |
04/5/2018 09:53 | It is not 40% off because of the online statement but because of the profit warning last year. Agree on the debt for sure | harrogate | |
04/5/2018 09:38 | Maybe market is spooked at level of net debt rising? Management may need to have a year focusing on paying down the debt etc so that the yield can rise? Otherwise is there a seller in the back ground as can't see any particular reason with an inline statement that this should be nearly 40% off? DYOR | qs99 | |
04/5/2018 09:29 | GHF - thanks for the sympathy! Very surprised that it went down after the statement and like you I have been impressed with the new CEO ( obviously only on video as you know I don't leave the house !!) The key I think will be debt reduction and making the UK business more profitable and no new acquisitions for a while. | harrogate | |
04/5/2018 09:16 | Well...I’ve stuck a few toes in the water! Held EMR on/off over the years & astounded to see it fall back to 75p yesterday, especially as they provided a brief “in line” on trading the previous day. 50% wiped off the share-price in the last 12 months. Sorry for holders. V impressed with new CEO in a few conference calls I’ve been party to over the years &’while the business will never command a high valuation, it looks incredibly cheap down here. Kind regards GHF | glasshalfull | |
03/5/2018 14:57 | Thanks, Graham. Yes, I've been watching the drift and more recently noticing the dearth of trades....then out of the blue comes this relatively high level of sells, with the last @ 74p. I had been on the point of buying, but for a computer glitch which unhinged that action ....thankfully so. I'll see what happens next.... gl f | fillipe | |
03/5/2018 14:49 | Filipe, look at the Stockopedia analysis of profit warnings ! “Anatomy of a Profit warning”. We should all sell immediately. The EMR chart is conforming exactly to the pattern of a “standard̶ I do not know what the actual reason is. | graham1ty | |
03/5/2018 14:28 | Why the drop, just now? f | fillipe | |
02/5/2018 07:14 | Think the AGM statement today was pretty positive - I have always thought Spencer was more impressive than Joust and this sounds like a good move and tightens up the structure and saves some money! Confirmation that at this stage they will hit the 2018 number which is 12.7p as above makes them decent value I think. If we see debt reduction in line with forecasts I can see this wanting to move above £1 again | harrogate | |
20/3/2018 18:53 | The presentation and stockopedia report for Empresaria who presented at our London seminar last week can be found here: | sharesoc | |
15/3/2018 07:19 | EMR were at ShareSoc last night. Pretty positive generally. New forecasts are for 12.7p this year and 12.8p in 2019 from Arden. And 12.7p and 12.9p from Allenby. Some were worried about net debt, but EMR have said they plan no acquisitions this year. Free cash flow last year was £12m, so it remains very cash generative. Allenby have debt debt falling to just £4m by end 2019 while Arden have net debt at just £1m by end 2019. EMR still have to bounce back from the disappointment of the trading statement last November and now rebuild confidence. Only then will theshare price recover. But yesterday was the sixth consecutive year of eps growth, so the market has been pretty harsh | graham1ty | |
14/3/2018 10:19 | Empresaria Group PLC (EMR) FY results 2017 CEO Joost Kreulen and Group Finance Director/COO Spencer Wreford, present highlights of the groups’ full year results to the 31st of December 2017. 7 mins Spencer Wreford, Group Finance Director /COO Overview – 00:22 Diversification – 1:25 Joost Kreulen, CEO Strategy – 2:55 Outlook – 5:57 | tomps2 | |
14/3/2018 08:38 | Here is what it says re the trading statement in November: . "We saw a reduction in net fee income in Germany following the introduction of new legislation to limit the amount of time a worker can be treated as a temporary worker at the same client to 18 months as well as new minimum wage rules. We have been proactive in managing this position with worker rotations but this has resulted in lower temporary margins and a subsequent decline in profit. In the Middle East we have incurred restructuring costs in the year, bringing the cost base in line with current trading and whilst loss making, it was an improvement on the prior year and we saw a positive trend across the second half." | this_is_me | |
14/3/2018 07:14 | Those are pretty good, but only on an adjusted, adjusted, adjusted basis. I have only skimmed the results and there is next to nothing on the problems of the trading statement | graham1ty | |
13/3/2018 15:49 | Results tomorrow. No sign of a leak ( on the upside) and a few sellers. | graham1ty | |
24/1/2018 07:45 | Record results for 2017. | this_is_me | |
19/12/2017 16:15 | Great buy at these levels, way undervalued! Just look at the cash generation and PE, common sense will prevail at some point soon | bennya | |
21/11/2017 18:41 | Switched my emr holding in to hvn couple of weeks back. Great buy back in opportunity could present itself here if it drops back much more imo | 5chipper | |
21/11/2017 07:47 | you should have sold... | asturius101 | |
12/9/2017 10:30 | Hard to understand why market sentiment is against this stock given the positive results. I'm happy to continue holding. | 1rsd | |
22/8/2017 20:59 | market doesn't agree, let's see who's right | deadly | |
22/8/2017 15:12 | Buy rating reiterated in IC today | mfhmfh | |
22/8/2017 14:51 | hxxps://www.research Capital Network have issued a research note | slopsjon2 | |
22/8/2017 10:21 | Well the market hasn't reacted well to those results. Hard to see what the company can do to get a positive reaction.Guess it's down to Brexit headwinds. | fittster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions